Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial.

Manzano S, Bailey B, Girodias JB, Galetto-Lacour A, Cousineau J, Delvin E.

Am J Emerg Med. 2010 Jul;28(6):647-53. doi: 10.1016/j.ajem.2009.02.022. Epub 2010 Jan 28.

PMID:
20637377
2.

Diagnostic value of procalcitonin in well-appearing young febrile infants.

Gomez B, Bressan S, Mintegi S, Da Dalt L, Blazquez D, Olaciregui I, de la Torre M, Palacios M, Berlese P, Ruano A.

Pediatrics. 2012 Nov;130(5):815-22. doi: 10.1542/peds.2011-3575. Epub 2012 Oct 29.

3.

Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department.

Andreola B, Bressan S, Callegaro S, Liverani A, Plebani M, Da Dalt L.

Pediatr Infect Dis J. 2007 Aug;26(8):672-7.

PMID:
17848876
4.

Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin.

Olaciregui I, Hernández U, Muñoz JA, Emparanza JI, Landa JJ.

Arch Dis Child. 2009 Jul;94(7):501-5. doi: 10.1136/adc.2008.146530. Epub 2009 Jan 21.

PMID:
19158133
5.

Procalcitonin as a marker of bacteremia in children with fever and a central venous catheter presenting to the emergency department.

Kasem AJ, Bulloch B, Henry M, Shah K, Dalton H.

Pediatr Emerg Care. 2012 Oct;28(10):1017-21. doi: 10.1097/PEC.0b013e31826caac2.

PMID:
23023470
6.

Procalcitonin as a marker of serious bacterial infections in febrile children younger than 3 years old.

Mahajan P, Grzybowski M, Chen X, Kannikeswaran N, Stanley R, Singal B, Hoyle J Jr, Borgialli D, Duffy E, Kuppermann N.

Acad Emerg Med. 2014 Feb;21(2):171-9. doi: 10.1111/acem.12316.

7.

Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.

Westwood M, Ramaekers B, Whiting P, Tomini F, Joore M, Armstrong N, Ryder S, Stirk L, Severens J, Kleijnen J.

Health Technol Assess. 2015 Nov;19(96):v-xxv, 1-236. doi: 10.3310/hta19960. Review.

8.

Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.

Maravić-Stojković V, Lausević-Vuk L, Jović M, Ranković A, Borzanović M, Marinković J.

Srp Arh Celok Lek. 2011 Nov-Dec;139(11-12):736-42.

9.

Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis.

Yo CH, Hsieh PS, Lee SH, Wu JY, Chang SS, Tasi KC, Lee CC.

Ann Emerg Med. 2012 Nov;60(5):591-600. doi: 10.1016/j.annemergmed.2012.05.027. Epub 2012 Aug 22. Review.

PMID:
22921165
10.

Markers for bacterial infection in children with fever without source.

Manzano S, Bailey B, Gervaix A, Cousineau J, Delvin E, Girodias JB.

Arch Dis Child. 2011 May;96(5):440-6. doi: 10.1136/adc.2010.203760. Epub 2011 Jan 29.

PMID:
21278424
11.

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B; ProHOSP Study Group.

JAMA. 2009 Sep 9;302(10):1059-66. doi: 10.1001/jama.2009.1297.

PMID:
19738090
12.

Is procalcitonin useful in early diagnosis of serious bacterial infections in children?

Thayyil S, Shenoy M, Hamaluba M, Gupta A, Frater J, Verber IG.

Acta Paediatr. 2005 Feb;94(2):155-8.

PMID:
15981747
13.
14.

Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.

Gendrel D, Raymond J, Coste J, Moulin F, Lorrot M, Guérin S, Ravilly S, Lefèvre H, Royer C, Lacombe C, Palmer P, Bohuon C.

Pediatr Infect Dis J. 1999 Oct;18(10):875-81.

PMID:
10530583
15.
16.

Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial.

Tang J, Long W, Yan L, Zhang Y, Xie J, Lu G, Yang C.

BMC Infect Dis. 2013 Dec 17;13:596. doi: 10.1186/1471-2334-13-596.

17.

Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker.

Fernández Lopez A, Luaces Cubells C, García García JJ, Fernández Pou J; Spanish Society of Pediatric Emergencies.

Pediatr Infect Dis J. 2003 Oct;22(10):895-903.

PMID:
14551491
18.

Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department.

Hausfater P, Juillien G, Madonna-Py B, Haroche J, Bernard M, Riou B.

Crit Care. 2007;11(3):R60.

19.

[Value of serum procalcitonin for the guidance of antibiotic therapy in children with lower respiratory tract infection].

Dai BQ, Yuan XT, Liu JM.

Zhongguo Dang Dai Er Ke Za Zhi. 2015 Dec;17(12):1292-6. Chinese.

20.

Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.

Verduri A, Luppi F, D'Amico R, Balduzzi S, Vicini R, Liverani A, Ruggieri V, Plebani M, Barbaro MP, Spanevello A, Canonica GW, Papi A, Fabbri LM, Beghè B; FARM58J2XH Study Group.

PLoS One. 2015 Mar 11;10(3):e0118241. doi: 10.1371/journal.pone.0118241. eCollection 2015.

Supplemental Content

Support Center